3Grant LM, Lisker-Melman M. Nonalcoholic fatty liver disease. Ann Hepatol, 2004, 3: 93-99.
4Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology, 2003, 37: 1202-1219.
5Yu J, Ip E, Dela Pena A, et al. COX-2 induction in mice with experimental nutritional steatohepatitis: Role as pro-inflammatory mediator. Hepatology, 2006, 43:826-836.
4Courivaud C,Bamoulid J,Tiberghien P,et al.G-765C COX-2 gene promoter polymorphism and risk of atherosclerosis after kidney transplantation.Transplantation,2009,88:851-852.
5Pandey S,Mittal RD,Srivastava M,et al.Cyclooxygenase-2 gene polymorphisms and risk of cervical cancer in a North Indian population.Int J Gynecol Cancer,2010,20:625-630.
6Koopmann J,Rosenzweig CN,Zhang Z,et al.Serum markers in patients with resectable pancreatic adenocarcinoma:macrophage inhibitory cytokine i versus CA19-9.Clin Cancer Res,2006,12:442-446.
7Lowenfels AB,Maisonneuve P,Whitcomb DC,et al.Cigarette smoking as a risk factor for pancreatic cancer ia patients with hereditary pancreatitis.JAMA,2001,286:169-170.
8Grφnborg M,Bunkenborg J,Kristiansen TZ,et al.Comprehensive proteomic analysis of human pancreatic juice.J Proteome Res,2004,3:1042-1055.
9Nanji AA,Miao L,Thomas P,et al.Enhanced cyclooxygenase-2 gene expression in alcoholic liver disease in the rat.Gastroenterology,1997,112:943-951.
10Enomoto N,Ikejima K,Yamashina S,et al.Kupffer cell-derived prostaglandin E(2) is involved in alcohol-induced fat accumulation in rat liver.Am J Physiol Gastrointest Liver Physiol,2000,279:G100-106.
